Case Report: Use of mirvetuximab soravtansine in a patient with platinum-resistant ovarian cancer and concomitant PARP-inhibitor-related myelodysplastic syndrome.
Saved in:
| Title: | Case Report: Use of mirvetuximab soravtansine in a patient with platinum-resistant ovarian cancer and concomitant PARP-inhibitor-related myelodysplastic syndrome. |
|---|---|
| Authors: | Njonou Noujiep SS; Department of Gynecology with Center of Oncological Surgery, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Altmann J; Department of Gynecology with Center of Oncological Surgery, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Bullinger L; Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (Deutsches Konsortium Für Translationale Krebsforschung, DKTK), Berlin, Germany.; National Center for Tumor Diseases (NCT), Berlin, Germany., Sehouli J; Department of Gynecology with Center of Oncological Surgery, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (Deutsches Konsortium Für Translationale Krebsforschung, DKTK), Berlin, Germany.; National Center for Tumor Diseases (NCT), Berlin, Germany. |
| Source: | Frontiers in oncology [Front Oncol] 2026 Apr 20; Vol. 16, pp. 1785547. Date of Electronic Publication: 2026 Apr 20 (Print Publication: 2026). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42088210 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Case Report: Use of mirvetuximab soravtansine in a patient with platinum-resistant ovarian cancer and concomitant PARP-inhibitor-related myelodysplastic syndrome. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Njonou+Noujiep+SS%22">Njonou Noujiep SS</searchLink>; Department of Gynecology with Center of Oncological Surgery, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Altmann+J%22">Altmann J</searchLink>; Department of Gynecology with Center of Oncological Surgery, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Bullinger+L%22">Bullinger L</searchLink>; Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (Deutsches Konsortium Für Translationale Krebsforschung, DKTK), Berlin, Germany.; National Center for Tumor Diseases (NCT), Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Sehouli+J%22">Sehouli J</searchLink>; Department of Gynecology with Center of Oncological Surgery, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (Deutsches Konsortium Für Translationale Krebsforschung, DKTK), Berlin, Germany.; National Center for Tumor Diseases (NCT), Berlin, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2026 Apr 20; Vol. 16, pp. 1785547. <i>Date of Electronic Publication: </i>2026 Apr 20 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Case Reports; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42088210 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fonc.2026.1785547 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1785547 Titles: – TitleFull: Case Report: Use of mirvetuximab soravtansine in a patient with platinum-resistant ovarian cancer and concomitant PARP-inhibitor-related myelodysplastic syndrome. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Njonou Noujiep SS – PersonEntity: Name: NameFull: Altmann J – PersonEntity: Name: NameFull: Bullinger L – PersonEntity: Name: NameFull: Sehouli J IsPartOfRelationships: – BibEntity: Dates: – D: 20 M: 04 Text: 2026 Apr 20 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 2234-943X Numbering: – Type: volume Value: 16 Titles: – TitleFull: Frontiers in oncology Type: main |
| ResultId | 1 |
